Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cerus Corp (NQ: CERS )

6.165 USD -0.185 (-2.91%)
Streaming Delayed Price Updated: 1:18 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Cerus Corp

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Cerus Announces Collaboration Agreement With Haemonetics for the Use of Acrodose Platelet Kits With the INTERCEPT Blood System for Platelets
Cerus Announces Collaboration Agreement With Haemonetics for the Use of Acrodose Platelet Kits With the INTERCEPT Blood System for Platelets 
From Business Wire News Releases
Cerus and The Community Blood Center Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Cerus and The Community Blood Center Enter into Agreement for the Use of INTERCEPT Platelets and Plasma 
From Business Wire News Releases
Market Data on Movers and Shakers - Research on Cerus, Eldorado Resorts, Shoe Carnival and Pacific Premier Bancorp
Tags Business & Professional Services
From ACCESSWIRE
Cerus Corporation Reports Third Quarter 2015 Results
Cerus Corporation Reports Third Quarter 2015 Results 
From Business Wire News Releases
Cerus and OneBlood Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Cerus and OneBlood Enter into Agreement for the Use of INTERCEPT Platelets and Plasma 
From Business Wire News Releases
Direction of Market Influences - Research on Cerus, Arena Pharmaceuticals, Walter Investment Management and AngioDynamics
Tags Business & Professional Services
From ACCESSWIRE
Cerus to Present at the Stephens 2015 Fall Investment Conference on November 10, 2015
Cerus to Present at the Stephens 2015 Fall Investment Conference on November 10, 2015 
From Business Wire News Releases
Cerus Corporation Announces CMS Issuance of Permanent P-Codes for Outpatient Hospital Billing of Pathogen-Reduced Platelets and Plasma
Cerus Corporation Announces CMS Issuance of Permanent P-Codes for Outpatient Hospital Billing of Pathogen-Reduced Platelets and Plasma 
From Business Wire News Releases
Cerus to Release Third Quarter 2015 Results on November 5, 2015
Cerus to Release Third Quarter 2015 Results on November 5, 2015 
From Business Wire News Releases
Cerus Corporation Announces New Agreement With Fresenius Kabi for the Production of INTERCEPT Blood System Kits
Cerus Corporation Announces New Agreement With Fresenius Kabi for the Production of INTERCEPT Blood System Kits 
From Business Wire News Releases
Cerus and the Community Blood Center of the Carolinas Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Cerus and the Community Blood Center of the Carolinas Enter into Agreement for the Use of INTERCEPT Platelets and Plasma 
From Business Wire News Releases
Equities Review on the Healthcare Sector -- Cerus, Cross Country Healthcare, Alder BioPharmaceuticals, Antares Pharma and CEPHEID
From PR Newswire
Biotechnology Stocks Technical Data -- Anacor Pharma, CytRx, Cerus, CorMedix, and FibroGen
From PR Newswire
Cerus to Release Second Quarter 2015 Results on August 6, 2015
From Business Wire News Releases
Cerus to Present at Cantor Fitzgerald’s Inaugural Healthcare Conference on July 8, 2015
From Business Wire News Releases
First INTERCEPT Pathogen Reduced Platelet Units Produced in the Continental US
From Business Wire News Releases
Richard J. Benjamin, MD PhD Appointed as Cerus Corporation’s New Chief Medical Officer
From Business Wire News Releases
Cerus Corporation Reports First Quarter 2015 Results
From Business Wire News Releases
Cerus to Present at AABB Symposium on Pathogen-Reduced Components
From Business Wire News Releases
Cerus to Release First Quarter 2015 Results on May 5, 2015
From Business Wire News Releases
First Patient Enrolled in Cerus' TRUE Study With the American Red Cross to Address Chikungunya and Dengue Blood Safety Risks With Pathogen Reduced Platelets
From Business Wire News Releases
Stock Updates on Health Care Equipment and Supplies Industry -- Stryker, Cerus, DENTSPLY Intl., Edwards Lifesciences, and Align Technology
From PR Newswire
Cerus Signs INTERCEPT Platelet Agreement With Sweden’s Largest Blood Product Supplier
From Business Wire News Releases
Cerus Corporation Reports Fourth Quarter and Year-End 2014 Results
From Business Wire News Releases
Cerus to Present at the Cowen and Company 35th Annual Health Care Conference on March 3, 2015
From Business Wire News Releases
Cerus to Release Fourth Quarter 2014 Results on February 26, 2015
From Business Wire News Releases
Cerus and SunCoast Blood Bank Enter Into Agreement for the Use of INTERCEPT Platelets and Plasma
From Business Wire News Releases
Cerus and Blood Bank of Delmarva Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
From Business Wire News Releases
Ash Stevens to Manufacture Amotosalen Active Pharmaceutical Ingredient for Cerus' INTERCEPT Blood System
From PR Newswire
Health Care Supplies Stocks Technical Review - Cerus, Unilife, DENTSPLY Intl., Alere, and Align Technology
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.